NCT07361614 Pilot Testing of a Colorectal Cancer Education Program
| NCT ID | NCT07361614 |
| Status | Recruiting |
| Phase | — |
| Sponsor | NYU Langone Health |
| Condition | Colorectal Cancer Screening |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-02-05 |
| Primary Completion | 2027-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-02-05 with a primary completion date of 2027-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of this study is to assess the feasibility, acceptability, and preliminary efficacy of a culturally and linguistically targeted, colorectal cancer (CRC) education program to improve CRC screening completion.
Eligibility Criteria
Inclusion Criteria: 1. Age 45-75 years 2. Not guideline concordant (no stool testing for CRC within past 1 year) 3. No colonoscopy in past 10 years; no sigmoidoscopy or CT colonography in past 5 years) 4. Understands English or Chinese languages. 5. Willing and able to consent to participate Exclusion Criteria: 1\) history of CRC or colectomy
Contact & Investigator
Suzanne Vang
PRINCIPAL INVESTIGATOR
NYU Langone Health
Frequently Asked Questions
Who can join the NCT07361614 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, up to 75 Years, studying Colorectal Cancer Screening. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07361614 currently recruiting?
Yes, NCT07361614 is actively recruiting participants. Contact the research team at Angel.mui@nyulangone.org for enrollment information.
Where is the NCT07361614 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT07361614 clinical trial?
NCT07361614 is sponsored by NYU Langone Health. The principal investigator is Suzanne Vang at NYU Langone Health. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.